Abstract:Objective To develop an LC-MS/MS method for simultaneous determine the concentration of atorvastatin (AT) and its two active metabolites,ortho-hydmxyatorvastatin (o-AT) andpara-hydroxyatorvastatin (p-AT) in human plasma.Methods Deuterium-labeled compounds,o-AT-d5 and p-AT-d5were used as the internal standards.The analytes were extracted from human plasma through liquid liquid extraction method by using tert-butyl ether,after adding 5％ formic acid.The chromatographic separation was achieved on a CAPCELL PAK C18(2.0 mm× 100 mm,TYPE∶MG Ⅱ,5 μm) column with the mobile phase,consisted of a mixture of acetonitrile-5 mmol · L-1 ammonium acetate buffer-formic acid (46∶ 54∶ 0.143,v/v/v),in isocratic mode at a flow rate of 0.40 mL · min-1.Data acquisition was carried out in multiple reaction monitoring (MRM) mode.Analytes were detected on a tandem mass spectrometer,equipped with an electrospray ionization source that was operated in the positive mode,using the transitions of m/z 559.3→m/z 440.2 for atorvastatin,and m/z 575.3→m/z 440.2 for both ortho-and para-hydroxyatorvastatin.The selectivity,standard curve,precision and accuracy,extraction recoveries,matrix effect,carry over and stability were investigated.Results The linear range of atorvastatin was 0.05-100 ng · mL-1.The linear regression equation was y =4.35 × 10-2x + 3.43 × 10-4 (r =0.999 3) with the lower limit of quantitation (LLOQ) of 0.05 ng · mL-1.The linear range of ortho-atorvastatin was 0.05-50 ng· mL-1.The linear regression equation was y =1.03 × 10-1x + 6.93 × 10-4 (r =0.998 7) with the lower limit of quantitation (LLOQ) of 0.05 ng · mL-1.The linear range of para-atorvastatin was 0.05-5.0 ng · mL-1.The linear regression equation was y =5.35 × 10-1 x-2.26 × 10-3 (r =0.998 4) with the lower limit of quantitation (LLOQ) of 0.05 ng · mL-1.The intra-day and inter-day relative standard deviations (RSD) of LLOQ,low,medium1,medium2 and high concentrations of atorvastatin were both less than 15％.The extraction recoveries were 61.64％-90.29％.The matrix effects were 88.74％-105.62％.Conclusion The established method is rapid,sensitive,accurate,specific and reliable,and suitablefor simultaneous determination of atorvastatin and its active metabolites (ortho-atorvastatin and para-atorvastatin) in human plasma,which meets the needs of clinical therapeutic drug monitoring and pharmacokinetics research.

A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma.

HPLC/APCI -MS Determination of Telmisartan in Human Plasma

Simultaneous Determination of Hydrochlorothiazide and Valsartan in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry

Liquid chromatographic-tandem mass spectrometric method for the simultaneous quantitation of telmisartan and hydrochlorothiazide in human plasma.

A Supercritical Fluid Chromatography and Tandem Mass Spectrometry Method for the Simultaneous Quantification of Valsartan and Hydrochlorothiazide in Human Plasma

Validation of a fast and reliable liquid chromatography tandem mass spectrometry for simultaneous quantitation of Voriconazole, Posaconazole and Linezolid in human serum

Determination of Hydrochlorothiazide in Human Plasma by Liquid Chromatography/tandem Mass Spectrometry.

High-Performance Liquid Chromatography-Mass Spectrometric Analysis of Ramipril and Its Active Metabolite Ramiprilat in Human Serum: Application to A Pharmacokinetic Study in the Chinese Volunteers

A SENSITIVE, ECONOMICAL BIOANALYTICAL LC-MS/MS METHOD FOR SIMULTANEOUS ANALYSIS OF IRBESARTAN AND HYDROCHLOROTHIAZIDE

Rapid and sensitive liquid chromatography tandem mass spectrometry method for the quantification of ambroxol in human plasma.

Rapid Quantification of Lisinopril in Human Plasma by Liquid Chromatography/tandem Mass Spectrometry

Simultaneous determination of atorvastatin and its active metabolites in human plasma by LC-MS/MS

A Multidirectional Pattern-Reconfigurable Patch Antenna With CSRR on the Ground

Validation of a fast and reliable liquid chromatography-tandem mass spectrometry (LC-MS/MS) with atmospheric pressure chemical ionization method for simultaneous quantitation of voriconazole, itraconazole and its active metabolite hydroxyitraconazole in human plasma.

Simultaneous Determination of Hyzetimibe and Its Main Active Metabolite in Plasma by LC-MS/MS and Its Application in PK Study.

Simultaneous Quantification of Benazepril, Gliclazide and Valsartan in Human Plasma by LC–MS–MS and Application for Rapidly Measuring Protein Binding Interaction Between Rhein and These Three Drugs

Development and Validation of Ultra-Performance Liquid Chromatography (UPLC) Method for Simultaneous Quantification of Hydrochlorothiazide, Amlodipine Besylate, and Valsartan in Marketed Fixed-Dose Combination Tablet

Development and Validation of a Method for Quantification of Lisinopril, Indapamide, Metoprolol, Valsartan, and Amoldipine in Human Blood Serum by HPLC-MS/MS

Determination of Telmisartan in Human Plasma by LC-MS/MS and Bioequivalence Study of It

Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of lisinopril in human plasma.

Liquid chromatography tandem mass spectrometry method for simultaneous determination of antidiabetic drugs metformin and glyburide in human plasma